Teaser Image JMCP Cover Image Teaser Text As an increasing number of orphan drugs are FDA approved, health care payers, employers, and providers are attempting to strike a balance between patient access to innovative treatments and overall affordability. Tags (Topics): Rare Diseases URL https://www.jmcp.org/doi/abs/10.18553/jmcp.2021.20553 Primary Taxonomy Tag Managed Care Practice Issues
